Viking Therapeutics' IPO

Viking Therapeutics raised a round of funding on April 29, 2015. Investors include Public.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking's research …

Articles about Viking Therapeutics' IPO: